Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
SamAltman, CEO of OpenAI, announced that AGI has not yet been achieved and the company plans to release new developments next month. He cautioned against high expectations fueled by social ...
Some results have been hidden because they may be inaccessible to you